Premium
R‐CHOP is not effective regimen in CD 5(+) DLBCL diagnosed by flow‐cytometry/immunohistochemistry, karyotype and BCL 2/ BCL 6 status and expression
Author(s) -
Rymkiewicz G.,
RomejkoJarosinska J.,
PaszkiewiczKozik E.,
Błachnio K.,
Kotarska M.,
Bystydzienski Z.,
DomanskaCzyz K.,
Ostrowska B.,
DabrowskaIwanicka A.,
Woroniecka R.,
Grygalewicz B.,
Osowiecki M.,
Jastrzebska A.,
Walewski J.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_78
Subject(s) - cd5 , bcl6 , chop , diffuse large b cell lymphoma , immunohistochemistry , medicine , lymphoma , germinal center , gastroenterology , oncology , b cell , immunology , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom